United States General Accounting Office. Drug safety: most drugs withdrawn in recent years had greater health risks for women. Washington, DC: Government Publishing Office; 2001.
Roth J, Etzioni R, Waters T, Pettinger M, Rossouw J, Anderson G, Chlebowski R, Manson J, Hlatky M, Johnson K. Economic return from the women’s health initiative Estrogen Plus Progestin clinical trial: a modeling study. Ann Intern Med. 2014;160(9):594–602.
Cornelison TL, Clayton J. Considering sex as a biological variable in biomedical research. Gend Genome. 2017; 1(2):89–93; Clayton J. Studying both sexes: a guiding principle for biomedicine. FASEB J. 2015;30:1–6.
Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature. 2014;505:612–3.
Schiebinger L. Has Feminism changed science? Cambridge, MA: Harvard University press; 1999.
Schiebinger L, Klinge I. Gendered Innovation in Health and Medicine. Gender: Zeitschrift für Geschlecht, Kultur, und Gesellschaft. 2015;2(2015):29–50.
European Commission. Fact sheet: gender equality in Horizon 2020. Brussels; 2013 December 9; European Commission. Vademecum on gender equality in Horizon 2020. Brussels: RTD-B7 Science with and for Society; 2016.
European Commission. European Commission. Horizon 2020. Monitoring Report 2015. Directorate-General for Research and Innovation. Brussels: European Commission, 53; 2016.
Canadian Institutes of Health Research (CIHR). Gender, sex and health research guide: a tool for CIHR applicants. Ottawa: Canadian Institutes of Health Research (CIHR); 2012. Enacted December 2010
Clayton J, Collins F. NIH to balance sex in cell and animal studies. Nature. 2014;509:282–3; Clayton JA. Studying both sexes: a guiding principle for biomedicine. FASEB J. 2016;30(2):519–24; Tannenbaum C, Schwarz JM, Clayton JA, de Vries GJ, Sullivan C. Evaluating sex as a biological variable in preclinical research: the devil in the details. Biol Sex Diff. 2016;7(1):13.
Schiebinger L, Schraudner M. Interdisciplinary approaches to achieving gendered innovations in science, medicine, and engineering1. Interdiscip Sci Rev. 2011;36(2):154–67.
For method of sex and gender analysis, see http://genderedinnovations.stanford.edu/methods-sex-and-gender-analysis.html.
Schiebinger L, Klinge I. Gendered innovations: how gender analysis contributes to research. Luxembourg: Publications Office of the European Union, Foreword by EC Commissioner for Research, Innovation, and Science, Máire Geoghegan-Quinn; 2013
Schiebinger L, Klinge I, Paik HY, Sánchez de Madariaga I, Schraudner M, Stefanick M (eds). Gendered innovations in science, health & medicine, engineering, and environment; 2011–2017. genderedinnovations.stanford.edu.
Ristvedt SL. The evolution of gender. JAMA Psychiatry. 2014;71(1):13–14. Oertelt-Prigione S, Parol R, Krohn S, Preißner R, Regitz-Zagrosek V. Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines. BMC Med. 2010;8(1):1.
Oertelt-Prigione S, Regitz-Zagrosek V (eds). Sex and gender aspects in clinical medicine. London: Springer; 2012; Regitz-Zagrosek V (ed). Sex and gender differences in pharmacology. London: Springer; 2012; Schenck-Gustafsson K, DeCola P, Pfaff D, Pisetsky D (eds). Handbook of clinical gender medicine. Basel: Karger; 2012.
Bairey Merz C, Mark S, Boyan B, Jacoba A, Shah P, Shaw L, Taylor D, Marbán E. Proceedings from the scientific symposium: sex differences in cardiovascular disease and implications for therapies. J Women’s Health. 2010;19(6):1059–72.
Bugiardini R, Bairey Merz C. Angina with “normal” coronary arteries: a changing philosophy. J Am Med Assoc. 2005;293(4):477–84.
Robinson J, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, Ockene J, Blanchette P, Ko M. Cardiovascular risk in women with non-specific chest pain (from the women’s health initiative hormone Trials). Am J Cardiol. 2008;102(6):693–9.
GenCAD Partners. Gender in coronary artery disease. Brussels.: European Union; 2017.
Pelletier R, Ditto B, Pilote L. A composite measure of gender and its association with risk factors in patients with premature acute coronary syndrome. Psychosom Med. 2015;77(5):517–26. See also Schiebinger L, Stefanick ML. Gender matters in biological research and medical practice; 2016.
Bem SL. The measurement of psychological androgyny. J Consult Clin Psychol. 1974;42:155–62.
Bekker MHJ. Investigating gender within health research is more than sex disaggregation of data: a multi-facet gender and health model. Psychol Health Med. 2003;8(2):231–43; Nowatzki N, Grant KR. Sex is not enough: the need for gender-based analysis in health research. Health Care Women Int. 2011;32(4):263–77.
Nielsen M, Brooks C Cullen M, Einstein G, Ioannidis J, Klinge I, LeBlanc H, Neilands T, Paik H, Peragine D, Pilote L, Prochaska J, Ristvedt S, Stefanick M, Schiebinger L. Gender variables in health research; in progress.
Tannenbaum C, Day D. Age and sex in drug development and testing for adults. Pharmacol Res. 2017;121:83–93.
http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetailDoc&id=28824&no=1 AGG position paper 2016: For a better integration of the gender dimension in the Horizon 2020 Work Programme 2018-2020.
For details, see http://genderedinnovations.stanford.edu/sex-and-gender-analysis-policies-major-granting-agencies.html
Ludwig S, et al. A successful strategy to integrate sex and gender medicine into a newly developed medical curriculum. J Women's Health. 2015;24(12):996–1005.